Vanda Pharmaceuticals Inc.
DE ˙ DB ˙ US9216591084
5,17 € ↓ -0,02 (-0,39%)
2026-06-04
DEL PRIS
SecurityDE:VM4 / Vanda Pharmaceuticals Inc.
InstitutionCitigroup Inc
Latest Disclosed Ownership89,164 shares
Latest Disclosed Value $ 616,123
Citigroup Inc ownership in VM4 / Vanda Pharmaceuticals Inc.

On May 11, 2026 - Citigroup Inc filed a 13F-HR form disclosing ownership of 89,164 shares of Vanda Pharmaceuticals Inc. (DE:VM4) valued at $512,693 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 152,491 shares of Vanda Pharmaceuticals Inc.. This represents a change in shares of -41.53% during the quarter. The current value of the position is $460,978 USD.

Citigroup Inc has a history of taking positions in derivatives of the underlying security (VM4) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:VM4 / Vanda Pharmaceuticals Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-11 2026-03-31 13F VANDA PHARMACEUTICALS COM 921659108 89,164 -63,327 -41.53 616 -54.17 0.0003
2026-02-13 2025-12-31 13F VANDA PHARMACEUTICALS COM 921659108 152,491 125,883 473.10 1,345 918.18 0.0006
2025-11-10 2025-09-30 13F VANDA PHARMACEUTICALS COM 921659108 26,608 -853,995 -96.98 133 -96.82 0.0001
2025-08-11 2025-06-30 13F VANDA PHARMACEUTICALS COM 921659108 880,603 484,113 122.10 4,156 128.48 0.0020
2025-05-12 2025-03-31 13F VANDA PHARMACEUTICALS COM 921659108 396,490 338,867 588.08 1,820 559.06 0.0009
2025-02-12 2024-12-31 13F VANDA PHARMACEUTICALS COM 921659108 57,623 -11,881 -17.09 276 -15.08 0.0002
2024-11-12 2024-09-30 13F VANDA PHARMACEUTICALS COM 921659108 69,504 54,434 361.21 326 282.35 0.0002
2024-08-12 2024-06-30 13F VANDA PHARMACEUTICALS COM 921659108 15,070 3,327 28.33 85 77.08 0.0001
2024-05-10 2024-03-31 13F VANDA PHARMACEUTICALS COM 921659108 11,743 2,483 26.81 48 23.08 0.0000
2024-02-09 2023-12-31 13F VANDA PHARMACEUTICALS COM 921659108 9,260 7,947 605.26 39 680.00 0.0000
2023-12-06 2023-09-30 13F/A-1 VANDA PHARMACEUTICALS COM 921659108 1,313 -113,307 -98.85 6 -99.34 0.0000
2023-11-09 2023-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,313 -113,307 6 0.0000
2023-08-10 2023-06-30 13F VANDA PHARMACEUTICALS COM 921659108 114,620 -107,230 -48.33 755 -49.87 0.0005
2023-05-11 2023-03-31 13F VANDA PHARMACEUTICALS COM 921659108 221,850 113,816 105.35 1,506 88.72 0.0011
2023-02-09 2022-12-31 13F VANDA PHARMACEUTICALS COM 921659108 108,034 -51,885 -32.44 798 -49.49 0.0006
2022-11-10 2022-09-30 13F VANDA PHARMACEUTICALS COM 921659108 159,919 42,440 36.13 1,580 23.44 0.0011
2022-08-10 2022-06-30 13F VANDA PHARMACEUTICALS COM 921659108 117,479 35,095 42.60 1,280 37.34 0.0010
2022-05-12 2022-03-31 13F VANDA PHARMACEUTICALS COM 921659108 82,384 -69,490 -45.76 932 -60.89 0.0006
2022-02-10 2021-12-31 13F VANDA PHARMACEUTICALS COM 921659108 151,874 58,518 62.68 2,383 48.94 0.0013
2021-11-10 2021-09-30 13F VANDA PHARMACEUTICALS COM 921659108 93,356 -45,560 -32.80 1,600 -46.45 0.0009
2021-08-10 2021-06-30 13F VANDA PHARMACEUTICALS COM 921659108 138,916 -54,020 -28.00 2,988 3.11 0.0018
2021-05-13 2021-03-31 13F VANDA PHARMACEUTICALS COM 921659108 192,936 176,334 1,062.13 2,898 1,223.29 0.0019
2021-02-11 2020-12-31 13F VANDA PHARMACEUTICALS COM 921659108 16,602 10,435 169.21 219 265.00 0.0001
2020-11-12 2020-09-30 13F VANDA PHARMACEUTICALS COM 921659108 6,167 -52,776 -89.54 60 -91.10 0.0000
2020-08-12 2020-06-30 13F VANDA PHARMACEUTICALS COM 921659108 58,943 16,203 37.91 674 52.14 0.0005
2020-05-12 2020-03-31 13F VANDA PHARMACEUTICALS COM 921659108 42,740 13,450 45.92 443 -7.71 0.0004
2020-02-12 2019-12-31 13F VANDA PHARMACEUTICALS COM 921659108 29,290 -99,214 -77.21 480 -71.88 0.0003
2019-11-08 2019-09-30 13F VANDA PHARMACEUTICALS COM 921659108 128,504 10,860 9.23 1,707 3.02 0.0014
2019-08-12 2019-06-30 13F VANDA PHARMACEUTICALS COM 921659108 117,644 59,826 103.47 1,657 55.73 0.0013
2019-05-13 2019-03-31 13F VANDA PHARMACEUTICALS COM 921659108 57,818 -19,985 -25.69 1,064 -47.66 0.0010
2019-02-12 2018-12-31 13F VANDA PHARMACEUTICALS COM 921659108 77,803 24,511 45.99 2,033 66.23 0.0021
2018-11-13 2018-09-30 13F VANDA PHARMACEUTICALS COM 921659108 53,292 51,007 2,232.25 1,223 2,744.19 0.0011
2018-08-10 2018-06-30 13F VANDA PHARMACEUTICALS COM 921659108 2,285 560 32.46 43 48.28 0.0000
2018-05-11 2018-03-31 13F VANDA PHARMACEUTICALS COM 921659108 1,725 -87,146 -98.06 29 -97.85 0.0000
2018-02-12 2017-12-31 13F VANDA PHARMACEUTICALS COM 921659108 88,871 -39,182 -30.60 1,350 -41.10 0.0011
2017-11-13 2017-09-30 13F VANDA PHARMACEUTICALS COM 921659108 128,053 81,490 175.01 2,292 201.98 0.0019
2017-08-11 2017-06-30 13F VANDA PHARMACEUTICALS COM 921659108 46,563 14,063 43.27 759 66.45 0.0007
2017-05-12 2017-03-31 13F VANDA PHARMACEUTICALS COM 921659108 32,500 -106,287 -76.58 456 -79.40 0.0004
2017-02-10 2016-12-31 13F VANDA PHARMACEUTICALS COM 921659108 138,787 117,632 556.05 2,214 530.77 0.0020
2016-11-10 2016-09-30 13F VANDA PHARMACEUTICALS COM 921659108 21,155 14,729 229.21 351 387.50 0.0003
2016-08-12 2016-06-30 13F VANDA PHARMACEUTICALS COM 921659108 6,426 -30,114 -82.41 72 -76.39 0.0001
2016-05-13 2016-03-31 13F VANDA PHARMACEUTICALS COM 921659108 36,540 29,798 441.98 305 384.13 0.0003
2016-02-12 2015-12-31 13F VANDA PHARMACEUTICALS COM 921659108 6,742 -39,597 -85.45 63 -87.95 0.0001
2015-11-13 2015-09-30 13F VANDA PHARMACEUTICALS COM 921659108 46,339 34,830 302.63 523 258.22 0.0005
2015-08-13 2015-06-30 13F VANDA PHARMACEUTICALS COM 921659108 11,509 3,096 36.80 146 87.18 0.0001
2015-05-14 2015-03-31 13F VANDA PHARMACEUTICALS COM 921659108 8,413 -6,893 -45.03 78 -64.38 0.0001
2015-02-17 2014-12-31 13F VANDA PHARMACEUTICALS COM 921659108 15,306 14,127 1,198.22 219 1,725.00 0.0002
2014-11-14 2014-09-30 13F VANDA PHARMACEUTICALS COM 921659108 1,179 -3,210 -73.14 12 -83.10 0.0000
2014-08-14 2014-06-30 13F VANDA PHARMACEUTICALS COM 921659108 4,389 -4,199 -48.89 71 -49.29 0.0001
2014-05-15 2014-03-31 13F VANDA PHARMACEUTICALS COM 921659108 8,588 -4,507 -34.42 140 -13.58 0.0001
2014-02-14 2013-12-31 13F VANDA PHARMACEUTICALS COM 921659108 13,095 3,784 40.64 162 58.82 0.0001
2013-11-14 2013-09-30 13F VANDA PHARMACEUTICALS COM 921659108 9,311 6,804 271.40 102 385.71 0.0001
2013-08-14 2013-06-30 13F VANDA PHARMACEUTICALS COM 921659108 2,507 2,507 21 0.0000
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-02-11 2020-12-31 13F VANDA PHARMACEUTICALS COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-12 2020-09-30 13F VANDA PHARMACEUTICALS COM Call 1,500 15.38 14 -6.67 n/a n/a n/a
2020-08-12 2020-06-30 13F VANDA PHARMACEUTICALS COM Call 1,300 -63.89 15 -59.46 n/a n/a n/a
2020-05-12 2020-03-31 13F VANDA PHARMACEUTICALS COM Call 3,600 140.00 37 48.00 n/a n/a n/a
2020-02-12 2019-12-31 13F VANDA PHARMACEUTICALS COM Call 1,500 650.00 25 733.33 n/a n/a n/a
2019-11-08 2019-09-30 13F VANDA PHARMACEUTICALS COM Call 200 -80.00 3 -78.57 n/a n/a n/a
2019-08-12 2019-06-30 13F VANDA PHARMACEUTICALS COM Call 1,000 -23.08 14 -41.67 n/a n/a n/a
2019-05-13 2019-03-31 13F VANDA PHARMACEUTICALS COM Call 1,300 -38.10 24 -56.36 n/a n/a n/a
2019-02-12 2018-12-31 13F VANDA PHARMACEUTICALS COM Call 2,100 -48.78 55 -41.49 n/a n/a n/a
2018-11-13 2018-09-30 13F VANDA PHARMACEUTICALS COM Call 4,100 241.67 94 308.70 n/a n/a n/a
2018-08-10 2018-06-30 13F VANDA PHARMACEUTICALS COM Call 1,200 -85.54 23 -83.57 n/a n/a n/a
2018-05-11 2018-03-31 13F VANDA PHARMACEUTICALS COM Call 8,300 40.68 140 55.56 n/a n/a n/a
2018-02-12 2017-12-31 13F VANDA PHARMACEUTICALS COM Call 5,900 -45.37 90 -53.37 n/a n/a n/a
2017-11-13 2017-09-30 13F VANDA PHARMACEUTICALS COM Call 10,800 208.57 193 238.60 n/a n/a n/a
2017-08-11 2017-06-30 13F VANDA PHARMACEUTICALS COM Call 3,500 -44.44 57 -35.23 n/a n/a n/a
2017-05-12 2017-03-31 13F VANDA PHARMACEUTICALS COM Call 6,300 3,050.00 88 2,833.33 n/a n/a n/a
2017-02-10 2016-12-31 13F VANDA PHARMACEUTICALS COM Call 200 -94.87 3 -95.38 n/a n/a n/a
2016-11-10 2016-09-30 13F VANDA PHARMACEUTICALS COM Call 3,900 3,800.00 65 6,400.00 n/a n/a n/a
2016-08-12 2016-06-30 13F VANDA PHARMACEUTICALS COM Call 100 -91.67 1 -90.00 n/a n/a n/a
2016-05-13 2016-03-31 13F VANDA PHARMACEUTICALS COM Call 1,200 0.00 10 -9.09 n/a n/a n/a
2016-02-12 2015-12-31 13F VANDA PHARMACEUTICALS COM Call 1,200 -20.00 11 -35.29 n/a n/a n/a
2015-11-13 2015-09-30 13F VANDA PHARMACEUTICALS COM Call 1,500 114.29 17 88.89 n/a n/a n/a
2015-08-13 2015-06-30 13F VANDA PHARMACEUTICALS COM Call 700 9 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2020-11-12 2020-09-30 13F VANDA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2020-08-12 2020-06-30 13F VANDA PHARMACEUTICALS COM Put 300 -75.00 3 -75.00 n/a n/a n/a
2020-05-12 2020-03-31 13F VANDA PHARMACEUTICALS COM Put 1,200 100.00 12 20.00 n/a n/a n/a
2020-02-12 2019-12-31 13F VANDA PHARMACEUTICALS COM Put 600 10 n/a n/a n/a
2019-11-08 2019-09-30 13F VANDA PHARMACEUTICALS COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-12 2019-06-30 13F VANDA PHARMACEUTICALS COM Put 5,300 -63.45 75 -71.91 n/a n/a n/a
2019-05-13 2019-03-31 13F VANDA PHARMACEUTICALS COM Put 14,500 116.42 267 52.57 n/a n/a n/a
2019-02-12 2018-12-31 13F VANDA PHARMACEUTICALS COM Put 6,700 3,250.00 175 3,400.00 n/a n/a n/a
2018-11-13 2018-09-30 13F VANDA PHARMACEUTICALS COM Put 200 -90.48 5 -87.50 n/a n/a n/a
2018-08-10 2018-06-30 13F VANDA PHARMACEUTICALS COM Put 2,100 2,000.00 40 1,900.00 n/a n/a n/a
2018-05-11 2018-03-31 13F VANDA PHARMACEUTICALS COM Put 100 -80.00 2 -75.00 n/a n/a n/a
2018-02-12 2017-12-31 13F VANDA PHARMACEUTICALS COM Put 500 0.00 8 -11.11 n/a n/a n/a
2017-11-13 2017-09-30 13F VANDA PHARMACEUTICALS COM Put 500 400.00 9 350.00 n/a n/a n/a
2017-08-11 2017-06-30 13F VANDA PHARMACEUTICALS COM Put 100 -98.59 2 -97.98 n/a n/a n/a
2017-05-12 2017-03-31 13F VANDA PHARMACEUTICALS COM Put 7,100 44.90 99 26.92 n/a n/a n/a
2017-02-10 2016-12-31 13F VANDA PHARMACEUTICALS COM Put 4,900 -9.26 78 -13.33 n/a n/a n/a
2016-11-10 2016-09-30 13F VANDA PHARMACEUTICALS COM Put 5,400 125.00 90 233.33 n/a n/a n/a
2016-08-12 2016-06-30 13F VANDA PHARMACEUTICALS COM Put 2,400 33.33 27 80.00 n/a n/a n/a
2016-05-13 2016-03-31 13F VANDA PHARMACEUTICALS COM Put 1,800 15 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.